Name: 神経血管デバイス/介入神経学市場 - 製品別（塞栓術（コイル、フローダイバーター）、ステント、バルーン閉塞デバイス、血栓除去装置、マイクロカテーテル）、病理学、地域別 - 2022年から2029年までの世界予測
Price: 3499 USD
Availability: InStock
Rating: 4.5 (100 reviews)
Author: Exactitude Consultancy
ISBN: 5589

神経血管デバイス/介入神経学市場の概要

世界の神経血管デバイス/介入神経学市場規模は、2020年には23億1,000万米ドルで、2029年までに49億2,000万米ドルまで成長し、年平均成長率（CAGR）は8.90%になると予想されています。

神経血管デバイスには、脳動脈瘤などの神経血管障害の治療に使用されるステントシステム、塞栓形成デバイス、神経血栓除去デバイスが含まれます。一般の人々の間でこれらの障害の罹患率が上昇していることと、治療法に関する認識を高めることを目的とした政府の取り組みが強化されていることから、こうした病気に対処するためのこれらの製品の需要が高まることが予想されます。

2021年1月に米国疾病管理予防センター（CDC）が発表したデータによると、米国では毎年約80万人が脳卒中を患っており、その75％以上が65歳以上の高齢者に発生しています。さらに、2022年の脳動脈瘤財団によると、世界中で毎年約1,500万人が脳卒中を経験しています。さらに、推定670万人が破裂していない脳動脈瘤を抱えており、米国では毎年約3万人が脳動脈瘤破裂を起こしています。

[キャプション id="attachment_9690" align="aligncenter" width="870"]

神経血管デバイス/介入神経学市場 | Exactitude Consultancy[/キャプション]

臨床的に有効であることが証明されている介入治療手順の採用が増加しており、神経疾患の診断、モニタリング、治療の強化を促進しています。神経血管デバイスの大幅な採用は、主要な市場全体で対象疾患に苦しむ患者層が広範かつ急速に拡大していることに主に起因しています。世界脳卒中機構（WSO）によると、2022年には世界中で約760万件の虚血性脳卒中の新規症例が記録されました。さらに、世界的に、肥満、高血圧、喫煙の蔓延、および高齢者人口の急増により、より多くの人口層が神経血管疾患にかかりやすい状態にあります。CDCによると、脳卒中のリスクは55歳を過ぎると10年ごとに倍増します。

Neurovascular devices are experiencing heightened demand among major stakeholders globally, driven by the escalating clinical research endeavors in the realm of neurovascular therapies, which furnish credible clinical data pertaining to their safety and efficacy profiles.

Neurovascular Devices/Interventional Neurology Market Segment Analysis

The neurovascular devices/interventional neurology market is segmented by product, pathology and end user Industry

On the basis of Product, global Neurovascular Devices/Interventional Neurology market is segmented into Embolization (Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters. Due to growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment, the embolization devices segment is expected to account for the largest share of the neurovascular devices/interventional neurology market.

On the basis of Pathology, global neurovascular devices/interventional neurology market is segmented into Stroke, Aneurysm, CAS, AVM. the cerebral aneurysm segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market, driven by neurosurgeons' increasing adoption of minimally invasive neurosurgical procedures, rising healthcare expenditure in emerging countries, and rising risk factors (such as high blood pressure, cigarette smoking, high cholesterol, diabetes, and obesity).

On the basis of End user industry, global Neurovascular Devices/Interventional Neurology market is segmented into Hospital, ASC, Research laboratories & academic institutes. Currently, hospitals and surgical centers are expected to have the greatest share of the worldwide neurovascular devices/interventional neurology market, while ambulatory care centers are expected to rise at the fastest rate throughout the anticipated period. The ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety and efficacy of these centers, as well as the ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety and efficacy of these centers, are expected to drive the growth of this end-user segment in the coming years.

[caption id="attachment_9691" align="alignnone" width="680"]

Neurovascular Devices/Interventional Neurology Market | Exactitude Consultancy[/caption]

Neurovascular Devices/Interventional Neurology Market Players

The Key Players in Neurovascular Devices/Interventional Neurology Market are Johnson & Johnson, Medtronic PLC, Stryker Corporation, Terumo Corporation, Penumbra Inc., MicroPort Scientific Corporation, Kaneka Corp., Integer Holdings Corporation, BALT.

September 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies* today announced that it has launched CERENOVUS Stroke Solutions™, which includes a suite of three devices designed to aid physicians in clot removal procedures. The announcement was made during the virtual European Society of Minimally Invasive Neurological Therapy (ESMINT).
In 2021, In light of Brexit, Pehnox formed a new corporation in the United Kingdom to boost its presence in important European markets.

Who Should Buy? Or Key Stakeholders

Industry and consulting firms
State and national regulatory authorities
Investors
Suppliers and Distributors
Research Institutes

Key Takeaways

The global Neurovascular Devices/Interventional Neurology Market is expected to grow at a CAGR of 8.90%.
On the basis of Product, embolization account for the largest share.
On the basis of Pathology, the cerebral aneurysm segment is expected to account for the largest share.
On the basis of End user industry, hospitals and surgical centers are expected to have the greatest share.
North America is expected to be the largest market for neurovascular devices and interventional neurology.
One major trend in the Neurovascular Devices/Interventional Neurology Market is the advancement of minimally invasive procedures and technologies for treating neurological conditions.

Neurovascular Devices/Interventional Neurology Market Regional Analysis

Geographically, Neurovascular Devices/Interventional Neurology market is segmented into North America, Europe, Asia Pacific, and Rest of the world.

North America: includes the US, Canada, Mexico
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC

North America is expected to be the largest market for neurovascular devices and interventional neurology. The growing target patient population for neurovascular diseases, rising awareness among neurosurgeons about the benefits of interventional neurology devices, and ongoing government initiatives to modernize and expand healthcare infrastructure are driving the neurovascular devices/interventional neurology market in North America. Furthermore, dropping product prices have improved the use of these gadgets, thus aiding market expansion in this area.

[caption id="attachment_9693" align="alignnone" width="680"]

Neurovascular Devices/Interventional Neurology Market | Exactitude Consultancy[/caption]

Key Market Segments: Neurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market by Product, (USD Millions) (Units)

Embolization (Coil, Flow Diverter)
Stents
Balloon Occlusion Devices
Clot Retrievers
Microcatheters

Neurovascular Devices/Interventional Neurology Market by Pathology, (USD Millions) (Units)

Stroke
Aneurysm
CAS
AVM

Neurovascular Devices/Interventional Neurology Market by End Use Industry, (USD Millions) (Units)

Hospital
ASC
Research Laboratories & Academic Institutes

Neurovascular Devices/Interventional Neurology Market by Region, (USD Millions) (Units)

North America
Europe
APAC
MEA
Latin America

Important Countries in All Regions Are Covered.

Objectives of the study

To provide an overall view of the market.
To detail out key pointers such as growth, market size, trends, drivers, restraints, challenges and opportunities in quantitative and qualitative terms
To provide a holistic view of market players and their activities to get an understanding of key growth strategies adopted

Key Question Answered

What is the current market size of this high growth market?
What is the overall growth rate?
What are the key growth areas, applications, end uses and types?
Key reasons for growth
Challenges for growth
What technological developments are happening in this area?

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions and Limitations

Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources

Executive Summary

Market Overview
1. Global Neurovascular Devices/Interventional Neurology Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact of Covid-19 On Neurovascular Devices/Interventional Neurology Market
3. Porter’s five forces model
  1. Threat from new entrants
  2. Threat from substitutes
  3. Bargaining power of suppliers
  4. Bargaining power of customers
  5. Degree of competition
4. Industry value chain Analysis

Global Neurovascular Devices/Interventional Neurology Market by Product
1. Embolization (coil, flow diverter)
2. Stents
3. Balloon occlusion devices
4. Clot retrievers
5. Microcatheters

Global Neurovascular Devices/Interventional Neurology Market by Pathology
1. Stroke
2. Aneurysm
3. Cas
4. AVM

Global Neurovascular Devices/Interventional Neurology Market by End Use Industry
1. Hospital
2. ASC
3. Research laboratories & academic institutes

Global Neurovascular Devices/Interventional Neurology Market by Region
1. North America
  1. US
  2. Canada
  3. Mexico
2. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest Of South America
3. Europe
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest Of Europe
4. Asia Pacific
  1. India
  2. China
  3. Japan
  4. South Korea
  5. Australia
  6. South-East Asia
  7. Rest Of Asia Pacific
5. Middle East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest Of Middle East and Africa

Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
1. Johnson & Johnson
2. Medtronic PLC
3. Stryker Corporation
4. Terumo Corporation
5. Penumbra, Inc.,
6. MicroPort Scientific Corporation
7. Kaneka Corp.
8. Integer Holdings Corporation
9. BALT *The Company List Is Indicative

LIST OF TABLES

TABLE 1                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 2                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 3                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 4                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 5                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 6                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 7                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 8                GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY REGION (UNITS) 2020-2029

TABLE 9                US NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 10              US NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 11              US NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 12              US NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 13              US NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 14              US NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 15              CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 16              CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 17              CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 18              CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 19              CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 20              CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 21              MEXICO NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 22              MEXICO NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 23              MEXICO NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 24              MEXICO NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 25              MEXICO NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 26              MEXICO NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 27              BRAZIL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 28              BRAZIL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 29              BRAZIL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 30              BRAZIL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 31              BRAZIL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 32              BRAZIL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 33              ARGENTINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 34              ARGENTINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 35              ARGENTINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 36              ARGENTINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 37              ARGENTINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 38              ARGENTINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 39              COLOMBIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 40              COLOMBIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 41              COLOMBIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 42              COLOMBIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 43              COLOMBIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 44              COLOMBIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 45              REST OF SOUTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 46              REST OF SOUTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 47              REST OF SOUTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 48              REST OF SOUTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 49              REST OF SOUTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 50              REST OF SOUTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 51              INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 52              INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 53              INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 54              INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 55              INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 56              INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 57              CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 58              CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 59              CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 60              CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 61              CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 62              CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 63              JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 64              JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 65              JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 66              JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 67              JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 68              JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 69              SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 70              SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 71              SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 72              SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 73              SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 74              SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 75              AUSTRALIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 76              AUSTRALIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 77              AUSTRALIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 78              AUSTRALIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 79              AUSTRALIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 80              AUSTRALIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 81              SOUTH-EAST ASIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 82              SOUTH-EAST ASIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 83              SOUTH-EAST ASIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 84              SOUTH-EAST ASIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 85              SOUTH-EAST ASIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 86              SOUTH-EAST ASIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 87              REST OF ASIA PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 88              REST OF ASIA PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 89              REST OF ASIA PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 90              REST OF ASIA PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 91              REST OF ASIA PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 92              REST OF ASIA PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 93              GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 94              GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 95              GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 96              GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 97              GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 98              GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 99              UK NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 100            UK NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 101            UK NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 102            UK NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 103            UK NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 104            UK NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 105            FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 106            FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 107            FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 108            FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 109            FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 110            FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 111            ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 112            ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 113            ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 114            ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 115            ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 116            ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 117            SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 118            SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 119            SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 120            SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 121            SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 122            SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 123            RUSSIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 124            RUSSIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 125            RUSSIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 126            RUSSIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 127            RUSSIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 128            RUSSIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 129            REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 130            REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 131            REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 132            REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 133            REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 134            REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 135            UAE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 136            UAE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 137            UAE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 138            UAE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 139            UAE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 140            UAE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 141            SAUDI ARABIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 142            SAUDI ARABIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 143            SAUDI ARABIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 144            SAUDI ARABIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 145            SAUDI ARABIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 146            SAUDI ARABIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 147            SOUTH AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 148            SOUTH AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 149            SOUTH AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 150            SOUTH AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 151            SOUTH AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 152            SOUTH AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

TABLE 153            REST OF MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 154            REST OF MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PRODUCT (UNITS) 2020-2029

TABLE 155            REST OF MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (USD MILLIONS) 2020-2029

TABLE 156            REST OF MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY PATHOLOGY (UNITS) 2020-2029

TABLE 157            REST OF MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (USD MILLIONS) 2020-2029

TABLE 158            REST OF MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET BY END USE INDUSTRY (UNITS) 2020-2029

図表一覧

図 1 市場のダイナミクス図 2 市場のセグメンテーション図 3 レポートのタイムライン: 検討対象年数図 4 データの三角測量図 5 ボトムアップアプローチ図 6 トップダウンアプローチ図 7 研究フロー図 8 世界の神経血管デバイス/介入神経学市場 (製品別、百万米ドル、2020-2029 年) 図 9 世界の神経血管デバイス/介入神経学市場 (病理別、百万米ドル、2020-2029 年) 図 10 世界の神経血管デバイス/介入神経学市場 (最終用途産業別、百万米ドル、 2020-2029 図 11 世界の神経血管デバイス/インターベンション神経学市場地域別、百万米ドル、2020-2029 図 12 ポーターの 5 つの力モデル図 13 北米の神経血管デバイス/インターベンション神経学市場のスナップショット図 14 ヨーロッパの神経血管デバイス/インターベンション神経学市場のスナップショット図 15 アジア太平洋の神経血管デバイス/インターベンション神経学市場のスナップショット図 16 南米の神経血管デバイス/インターベンション神経学市場のスナップショット図17 中東およびアフリカ神経血管デバイス/インターベンショナルニューロロジー市場スナップショット図 18 ジョンソン・エンド・ジョンソン企業スナップショット図 19 メドトロニック PLC 企業スナップショット図 20 ストライカーコーポレーション企業スナップショット図 21 テルモコーポレーション企業スナップショット図 22 ペナンブラインク企業スナップショット図 23 マイクロポートサイエンティフィックコーポレーション企業スナップショット図 24 カネカコーポレーション企業スナップショット図 25 インテグラーホールディングスコーポレーション企業スナップショット図 26 バルトカンパニースナップショット

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Neurovascular Devices/Interventional Neurology Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

神経血管デバイス/介入神経学市場 - 製品別（塞栓術（コイル、フローダイバーター）、ステント、バルーン閉塞デバイス、血栓除去装置、マイクロカテーテル）、病理学、地域別 - 2022年から2029年までの世界予測

Instant access to hundreds of data points and trends

神経血管デバイス/介入神経学市場の概要

Neurovascular Devices/Interventional Neurology Market Segment Analysis

Neurovascular Devices/Interventional Neurology Market Players

Who Should Buy? Or Key Stakeholders

Key Takeaways

Neurovascular Devices/Interventional Neurology Market Regional Analysis

Key Market Segments: Neurovascular Devices/Interventional Neurology Market

Objectives of the study

Key Question Answered

LIST OF TABLES

図表一覧

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept